Systemic administration of a novel development candidate, MTL-CEBPA, up-regulates the liver-enriched transcription factor C/EBP-α and reverses CCl4-induced liver failure in vivo

File(s)

Systemic administration of a novel development candidate, MTL-CEBPA, up-regulates the liver-enriched abstract.pdf (83.1 KB)

Accepted version

Show more

Author(s)

Reebye, V

Voutila, J

Huang, K-W

Muragundla, A

Jayaprakash, A

more

Type

Conference Paper

Date Issued

2015-10-07

Date Acceptance

2015-10-07

Citation

Hepatology, 2015, 62 (S1), pp.269A-270A

URI

http://hdl.handle.net/10044/1/32934

DOI

https://www.dx.doi.org/10.1002/hep.28185

ISSN

1527-3350

Publisher

Wiley

Start Page

269A

End Page

270A

Journal / Book Title

Hepatology

Volume

62

Issue

S1

Copyright Statement

© 2016 American Association for the Study of Liver Diseases. This is the accepted version of the following article: Vikash Reebye, Jon Voutila, Kai-Wen Huang, Anjaneyulu Muragundla, Aravindakshan Jayaprakash, Prashant Vadnal, Hans Huber, Robert Habib, Pål Sætrom, John Rossi, Nagy Habib, 'Systemic administration of a novel development candidate, MTL-CEBPA, up-regulates the liver-enriched transcription factor C/EBP-α and reverses CCl4-induced liver failure in vivo', Volume 62, Issue S1
October 2015, Pages 269A–270A, which has been published in final form at http://dx.doi.org/10.1002/hep.28185

Source

The 66th Annual Meeting of the American Association for the Study of Liver Diseases

Subjects

Science & Technology

Life Sciences & Biomedicine

Gastroenterology & Hepatology

1103 Clinical Sciences

1101 Medical Biochemistry And Metabolomics

Publication Status

Published

Start Date

2015-11-13

Finish Date

2015-11-17

Coverage Spatial

San Francisco, CA, USA